Explore more publications!
Tech News St. Vincent & Grenadines
Got News to Share?

Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 20, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
Feb. 20, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

Indeterminate GlobeNewswire
Purple Appoints Commercial Leader Tom Smith as Regional Growth Director to Lead North East Expansion and Social Impact Strategy
Feb. 20, 2026

Purple Appoints Commercial Leader Tom Smith as Regional Growth Director to Lead North East Expansion and Social Impact Strategy

Indeterminate GlobeNewswire
Big Blue Bubble Collaborates with T-Pain to Launch New 'Clubbox' Feature in My Singing Monsters
Feb. 20, 2026

Big Blue Bubble Collaborates with T-Pain to Launch New 'Clubbox' Feature in My Singing Monsters

Indeterminate GlobeNewswire
Gainwell Technologies and Medicaid Leaders to Highlight how States are Navigating H.R. 1 Requirements
Feb. 20, 2026

Gainwell Technologies and Medicaid Leaders to Highlight how States are Navigating H.R. 1 Requirements

Indeterminate GlobeNewswire
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
Feb. 20, 2026

Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

Indeterminate GlobeNewswire
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
Feb. 20, 2026

20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time

Indeterminate GlobeNewswire
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Feb. 20, 2026

PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval

Indeterminate GlobeNewswire
SEALSQ and Quobly Mutually Agree to Halt Discussions Regarding a Potential Majority Investment or Acquisition by SEALSQ
Feb. 20, 2026

SEALSQ and Quobly Mutually Agree to Halt Discussions Regarding a Potential Majority Investment or Acquisition by SEALSQ

Indeterminate GlobeNewswire
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
Feb. 20, 2026

CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference

Indeterminate GlobeNewswire
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
Feb. 20, 2026

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Indeterminate GlobeNewswire
Guardforce AI Announces Share Repurchase Program
Feb. 20, 2026

Guardforce AI Announces Share Repurchase Program

Indeterminate GlobeNewswire
Draganfly Welcomes Lieutenant-General (Ret’d) Michel Gauthier to Military Advisory Board in Support of Canada’s Defence Industrial Strategy
Feb. 20, 2026

Draganfly Welcomes Lieutenant-General (Ret’d) Michel Gauthier to Military Advisory Board in Support of Canada’s Defence Industrial Strategy

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
Feb. 20, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution

Indeterminate GlobeNewswire
CT3 Launches On-Chain Commerce Ecosystem and Debuts First OpenSea Integration
Feb. 20, 2026

CT3 Launches On-Chain Commerce Ecosystem and Debuts First OpenSea Integration

Indeterminate GlobeNewswire
Nasus Pharma to Participate in Upcoming Investor Conferences
Feb. 20, 2026

Nasus Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board
Feb. 20, 2026

AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board

Indeterminate GlobeNewswire
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
Feb. 20, 2026

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

Indeterminate GlobeNewswire
Society Pass Incorporated (Nasdaq: SOPA) and NusaTrip Incorporated (Nasdaq: NUTR) Respond to Nasdaq/SEC Questions Regarding Status of Trading of NUTR’s Securities; NusaTrip’s Operations Remain Normal and Unaffected by Trading Suspension
Feb. 20, 2026

Society Pass Incorporated (Nasdaq: SOPA) and NusaTrip Incorporated (Nasdaq: NUTR) Respond to Nasdaq/SEC Questions Regarding Status of Trading of NUTR’s Securities; NusaTrip’s Operations Remain Normal and Unaffected by Trading Suspension

Indeterminate GlobeNewswire
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Feb. 20, 2026

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Indeterminate GlobeNewswire
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
Feb. 20, 2026

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions